Hasil Pencarian - Muhasaparur Ganesan Rajanandh
- Menampilkan 1 - 5 hasil dari 5
-
1
-
2
Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19 oleh I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Justin Jacob Abraham, Muhasaparur Ganesan Rajanandh, Thangavel Mahalingam Vijayakumar
Diterbitkan 2021-01-01
Artikel -
3
Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19 oleh Justin Jacob Abraham, I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Muhasaparur Ganesan Rajanandh, Vijayakumar Thangavel Mahalingam
Diterbitkan 2021-01-01
Artikel -
4
Risk Factors and Surgical Site Infection in Patients with Surgical Antibiotic Prophylaxis in the Indian Population: A Prospective Cohort Study oleh Karthik Sankar, Deepika Anbalagan, Balaswetha Baskaran, Vysali Segaran, Yogitha Prabakar, Sridhar Raghu, Vidhya Krishna, Venkatesan Singaram, Xavier Santhiyagu, Muhasaparur Ganesan Rajanandh
Diterbitkan 2023-09-01
Artikel -
5
Barriers of healthcare professionals in utilizing the service of drugs and poison information Centre: A cross-sectional study oleh Harini Muralidharan, Arthi Venkatesan, Rishitha Venati, Indrani Devi Dhanasekaran, Teshini Suthahar, Abrar Ahmed, Arushi Salhotra, Bijisha Baburaj Nair, Mohana Krishnan, Muhasaparur Ganesan Rajanandh
Diterbitkan 2022-06-01
Artikel